Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by CrazyFrog2on Oct 13, 2018 9:16pm
26 Views
Post# 28795975

RE:RE:RE:RE:RE:RE:Latest from Phil

RE:RE:RE:RE:RE:RE:Latest from PhilThe most profitable segment is producing your own distillates and brand for vaping. Next is oils and your own brand. LDS can’t figure this out and obviously don’t have the capability to produce their own brand of distillates even though they have promoted for years they are. Just read their description above at top of page.  Nothing farther from the truth.    
CrazyFrog2 wrote: Many manufacturers now have transdermal delivery and sublingual cheek sprays or nasal sprays for anyone who prefers that delivery method. Much better methods and more convenient.  That’s another  fact !!!
CrazyFrog2 wrote: Give it a rest. The strips ain’t nothing unique or better than anything else that’s out there. As a matter of fact , no strips were huge sellers and not preferred by most. No one involved in or with LDS is highly regarded. This pumping
is pathetic ! That’s a fact.
Hempdoc wrote: Gunner...

Without having access to their research/patent text, all I can say is Dr. Sanderson & other members of the new scientific advisory board bring a lot to the table.  They are highly regarded in their fields & no doubt have spent countless hours on enhancing CannaStrips’ unique mechanism of delivery, which certainly has been thoroughly vetted for patentability by both the advisory board & their legal team.  Knowing who is involved & how much LDS has committed, I am pretty confident they will ultimately receive approval for their patent.  Having been granted several patents myself, this patent process though can be a long, arduous & expensive one.

I expect an announcement soon re: the filing of a non-provisional patent app, which will then set the stage for CannaStrip sales.  In the meantime, sales of their high-purity White Label products & Reveur should bring in enough revenue this qtr to add significant value to this company.

Good Luck

 




Bullboard Posts